/v1/protocols
The analytical workflow
Essayez-le en direct
10 appels gratuits par jour — sans inscription, sans clé API. Passe par la passerelle oanor.
Ça marche. Récupérez une clé API et utilisez-la dans votre projet.
Obtenez une clé APIExtraits de code
curl "https://api.oanor.com/metabolights-api/v1/protocols" \ -H "x-oanor-key: oanor_test_..."
await fetch("https://api.oanor.com/metabolights-api/v1/protocols", {
headers: { "x-oanor-key": "oanor_test_..." }
});
$ch = curl_init("https://api.oanor.com/metabolights-api/v1/protocols");
curl_setopt($ch, CURLOPT_HTTPHEADER, ["x-oanor-key: oanor_test_..."]);
curl_setopt($ch, CURLOPT_RETURNTRANSFER, true);
$out = curl_exec($ch);
import requests
requests.get(
"https://api.oanor.com/metabolights-api/v1/protocols",
headers={"x-oanor-key": "oanor_test_..."}
)
Exemple de réponse
Une réponse réelle de ce endpoint, capturée lors du dernier contrôle de santé.
{
"data": {
"count": 7,
"study": "MTBLS1",
"protocols": [
{
"name": "Sample collection",
"type": "Sample collection",
"parameters": [],
"description": "For the human studies, midstream urine (~15 ml) samples were collected and frozen from each volunteer. In total, 84 samples were collected from 12 healthy volunteers (7 time points, 8 males and 4 females) and 50 samples from 30 T2DM patients (1-3 time points, 17 males and 13 females) with well-controlled blood glucose maintained at normal concentrations by diet, following the guidelines issued by the American Diabetes Association, rather than medication. T2DM patients agreed to stop treatment with oral anti-diabetic agents during the study. Subjects went through a washout period of 4 wk before sample collection and abstained from alcohol during the study; diet was controlled throughout the study."
},
{
"name": "Extraction",
"type": "Extraction",
"parameters": [
"Extraction Method"
],
"description": "For the human studies, midstream urine (∼15 ml) samples were collected and frozen from each volunteer. In total, 84 samples were collected from 12 healthy volunteers (7 time points, 8 males and 4 females) and 50 samples from 30 T2DM patients (1–3 time points, 17 males and 13 females) with well-controlled blood glucose maintained at normal concentrations by diet, following the guidelines issued by the American Diabetes Association, rather than medication. The healthy subjects were aged 18–55 yr, had a body mass index (BMI) ≥19 and ≤30 kg/m2 and a body mass ≥50 kg and ≤113 kg, and were free from any major disease or pregnancy. The T2DM patients were aged 30–65 yr (mean 56 ± 9 yr), had a BMI >25 and <40 kg/m2, weighed between 65 and 140 kg (mean 95 ± 19 kg), and were taking at most one oral anti-diabetic drug. T2DM patients agreed to stop treatment with oral anti-diabetic agents during the study. Subjects went through a washout period of 4 wk before sample collection and abstained from alcohol during the study; diet was controlled throughout the study."
},
{
"name": "NMR sample",
"type": "NMR sample",
"parameters": [
"NMR tube type",
"Solvent",
"Sample pH",
"Temperature"
],
"description": "Aliquots of 400 µl urine samples were made up to 600 µl with phosphate buffer (0.2 M, pH 7.4) and any precipitate removed by centrifugation. In total, 500 µl of supernatant were transferred to 5-mm NMR tubes with 100 µl of sodium 3-trimethylsilyl-(2,2,3,3-2H4)-1-propionate (TSP)/D2O/sodium azide solution (0.05% wt/vol TSP in D2O and 1% wt/vol sodium azide)."
},
{
"name": "NMR
…